Enovis CORP (ENOV) income statement
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3068% below fair value
$25.47−0.76 (-2.90%)
Close on Nov 20, 2026Market cap $1.47BP/E –Yield –
Enovis CORP income statement
Ratios
Latest available, balances at Jul 3, 2026
Profitability, TTM
- Gross margin
- 61.1%
- Operating margin
- -45.1%
- Net margin
- -48.0%
- Return on equity, FY2025
- -58.5%
Financial strength
- Current ratio
- 1.98
- Debt to equity
- 0.87
- Debt to assets
- 34.1%
- Cash to current liabilities
- 2.1%
Valuation
- P/E ratio
- –
- Price to sales
- 0.64
- Price to book
- 0.99
- Dividend yield
- –
See a number that looks wrong?